Key Highlights of the Canadian Thoracic Society's Position Statement on the Optimization of COPD Management During the Coronavirus Disease 2019 Pandemic

Mohit Bhutani; Paul Hernandez; Jean Bourbeau; Gail Dechman; Erika Penz; Raymond Aceron; Marla Beauchamp; Joshua Wald; Michael Stickland; Sharla-Rae Olsen; Donna Goodridge

doi:10.1016/j.chest.2020.05.530

Key Highlights of the Canadian Thoracic Society's Position Statement on the Optimization of COPD Management During the Coronavirus Disease 2019 Pandemic

Chest. 2020 Sep;158(3):869-872. doi: 10.1016/j.chest.2020.05.530. Epub 2020 May 16.

Authors

Affiliations

¹ Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada. Electronic address: mohit.bhutani@ualberta.ca.
² Department of Medicine, Dalhousie University, Halifax, NS, Canada.
³ Research Institute of the McGill University Health Centre, McGill University, Montreal, QC, Canada.
⁴ School of Physiotherapy, Dalhousie University, Halifax, NS, Canada.
⁵ Respiratory Research Centre, University of Saskatchewan, Saskatoon, SK, Canada.
⁶ Faculty of Nursing, University of Alberta, Edmonton, AB, Canada.
⁷ School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada.
⁸ Department of Medicine, McMaster University, Hamilton, ON, Canada.
⁹ Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
¹⁰ Department of Medicine, Heritage Medical Centre, Prince George, BC, Canada.

No abstract available

Keywords: COVID-19, coronavirus disease 2019; CTS, Canadian Thoracic Society; ICS, inhaled corticosteroid; LABA, long-acting beta-2-agonist; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Betacoronavirus
COVID-19
Canada
Consensus*
Coronavirus Infections / complications*
Coronavirus Infections / epidemiology
Disease Management*
Humans
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / epidemiology
Pulmonary Disease, Chronic Obstructive / complications
Pulmonary Disease, Chronic Obstructive / therapy*
SARS-CoV-2
Societies, Medical*
Thoracic Surgery*